What Happened?
Cambridge, MA-based CAMP4-Therapeutics Appointed Josh Brehm as Chief Executive Officer
About the Company
What if we told you that our bodies make use of only a few hundred different signaling pathways to control all of our 20,000 or so genes. We call it the gene circuitry code, unique for every gene in our body. CAMP4 has built a proprietary 4-D Gene Circuity Platform to codify the discrete set of combinatorial rules used by any human cell type central to disease pathology. By applying the power of computational biology and machine learning algorithms, CAMP4 is able to rapidly solve for druggable targets to control the output of any disease gene of interest.
About the Person
Josh Brehm is Chief Executive Officer at CAMP4 Therapeutics. Previously, Josh held various senior HR leadership roles in the industry.
Info Source
News
Short Profile